Bruker (BRKR) Net Equity Issued and Repurchased (2010 - 2025)

Bruker (BRKR) has reported Net Equity Issued and Repurchased for 16 consecutive years, with $200000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Net Equity Issued and Repurchased fell 93.75% year-over-year to $200000.0; the trailing twelve-month figure through Dec 2025 stood at $669.7 million (up 63.74% YoY), and the FY2025 full-year result was $669.7 million, up 63.74% from the prior year.
• Net Equity Issued and Repurchased fell to $200000.0 in Q4 2025 per BRKR's latest filing, from $664.2 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $664.2 million in Q3 2025 and bottomed at -$2.8 million in Q3 2024.
• Historically, Net Equity Issued and Repurchased has averaged $54.9 million across 5 years, with a median of $2.0 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Net Equity Issued and Repurchased slumped 240.0% in 2024, then jumped 23821.43% in 2025.
• Over 5 years, Net Equity Issued and Repurchased stood at $1.1 million in 2021, then soared by 81.82% to $2.0 million in 2022, then surged by 135.0% to $4.7 million in 2023, then plunged by 31.91% to $3.2 million in 2024, then slumped by 93.75% to $200000.0 in 2025.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $200000.0, $664.2 million, and $4.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.